Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, Ikeda S, Hirayama A, Yamamoto T, Yoshida H, Otsuka M, Tsuji S, Yatomi Y, Sakuragawa T, Watanabe H, Nihei K, Saito T, Kawata S, Suzuki H, Tomita M, Suematsu M.
Soga T, et al. Among authors: hirayama a.
J Hepatol. 2011 Oct;55(4):896-905. doi: 10.1016/j.jhep.2011.01.031. Epub 2011 Feb 18.
J Hepatol. 2011.
PMID: 21334394
Clinical Trial.